A detailed history of Capital Advisors, Ltd. LLC transactions in Generation Bio Co. stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 29 shares of GBIO stock, worth $24. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29
Previous 38 23.68%
Holding current value
$24
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$2.16 - $3.51 $19 - $31
-9 Reduced 23.68%
29 $0
Q1 2024

Apr 18, 2024

BUY
$1.73 - $4.07 $65 - $154
38 New
38 $0
Q3 2022

Nov 09, 2022

BUY
$4.68 - $8.34 $163 - $291
35 New
35 $0
Q2 2022

Aug 05, 2022

SELL
$4.87 - $9.41 $58 - $112
-12 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$4.16 - $7.76 $49 - $93
12 New
12 $0

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $50.7M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Capital Advisors, Ltd. LLC Portfolio

Follow Capital Advisors, Ltd. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.